PURPOSE: This study was conducted to identify awareness levels and influencing factors of sexual harassment and gender egalitarianism among college students. METHODS: This study was based on a questionnaire survey with a total of 1,244 college students. The copies of the questionnaire were collected from November 2 to December 20, 2011. RESULTS: The average level of sexual harassment and gender egalitarianism among students from the Youngnam province was higher than those of other province. The average level of the sexual harassment and gender egalitarianism among those students who were majoring in healthcare sciences was higher than that among those who were majoring in other subjects than arts and sports sciences. The influencing factors on the recognition of gender egalitarianism were genders and sexual experiences. The influencing factors on the recognition of sexual harassment were genders and ages. CONCLUSION: This study identified college students' awareness of sexual harassment, gender egalitarianism and influencing factors associated with them. It is expected that this study will be helpful for developing strategies for the prevention of sexual harassment for college students.
Coat Protein Complex I ; Delivery of Health Care ; Humans ; Sexual Harassment ; Sports ; Surveys and Questionnaires

This study investigated the effects of high amylose starch (HAS) consumption on gut functions in male Sprague-Dawley rats. Experimental animals were fed an diet containing HAS for 4 weeks (0, 125, 250, 500 g/kg diet). Stool weights, transit time, the pH of cecum, Bifidobacterium growth, short chain fatty acid production, and prostaglandin E2 production in colon mucus were measured. HAS intake did not affect body weight gain or food efficiency ratio during experimental period. There were no significant differences in kidney weight, epididymal fat pad weights or spleen weights, but the weights of the liver and thymus were significantly lower in the HAS100 group. The length of the large intestine, the weights of the cecum wall and cecum contents, and stool weights significantly increased through HAS intake. But transit time was not affected by the experimental diet. Although Bifidobacterium growth in the cecum increased through the HAS intake dose dependently, there were significant differences in the HAS50 and HAS100 groups. HAS intake increased the production of short chain fatty acid in the cecum contents. In particular, acetate and butyrate concentrations grew significantly. And the production of prostaglandin E2 in the colon mucus significantly decreased through HAS intake. These results demonstrate that high amylose starch intake significantly improves gut function.
Adipose Tissue ; Amylose* ; Animals ; Bifidobacterium ; Body Weight ; Butyrates ; Cecum ; Colon ; Diet ; Dinoprostone ; Humans ; Hydrogen-Ion Concentration ; Intestine, Large ; Kidney ; Liver ; Male ; Mucus ; Rats* ; Rats, Sprague-Dawley ; Spleen ; Starch* ; Thymus Gland ; Weights and Measures

No abstract available.
Animals ; Bile Duct Neoplasms/*diagnosis/parasitology/pathology ; *Bile Ducts, Intrahepatic ; Cholangiocarcinoma/*diagnosis/parasitology/pathology ; Clonorchiasis/*complications/pathology ; Clonorchis sinensis/*isolation & purification ; Humans ; Male ; Middle Aged

No abstract available.
Bile Duct Neoplasms/complications/*diagnosis/pathology ; *Bile Ducts, Intrahepatic/pathology ; Cholangiocarcinoma/complications/*diagnosis/pathology ; Female ; Humans ; Lithiasis/*etiology/pathology/surgery ; Liver Diseases/*etiology/pathology/surgery ; Middle Aged

No abstract available.
Aged ; Bile Duct Neoplasms/*diagnosis/pathology ; *Bile Ducts, Intrahepatic ; Carcinoma, Papillary/*diagnosis/pathology ; Cholangiocarcinoma/*diagnosis/pathology ; Female ; Humans

No abstract available.
Bile Duct Neoplasms/*diagnosis/pathology ; *Bile Ducts, Intrahepatic ; Carcinoma, Hepatocellular/*diagnosis/pathology ; Cholangiocarcinoma/*diagnosis/pathology ; Humans ; Liver Neoplasms/*diagnosis/pathology ; Male ; Middle Aged ; Mixed Tumor, Malignant/*diagnosis/pathology

Nonalcoholic steatohepatitis (NASH), one of the NAFLDs (nonalcoholic fatty liver diseases), is regarded as a hepatic manifestation of metabolic syndrome. NASH can progress to cirrhosis, and possibly to hepatic malignancy. Currently, liver biopsy is the only reliable method of assessing the presence or absence of NASH and the stage of fibrosis. The finding of steatosis with evidence of hepatocyte injury such as inflammation, ballooning, degeneration, and/or fibrosis, is generally essential for making a diagnosis of NASH. However, its diagnostic criteria have not yet been established. The pathologic findings of NASH and related diseases, and the grading system currently in use are reviewed herein.
Biopsy, Fine-Needle ; Fatty Liver/diagnosis/*pathology ; Fibrosis/pathology ; Humans ; Severity of Illness Index

No abstract available.
Aged ; Bile Duct Neoplasms/*diagnosis/pathology/secretion ; Bile Ducts, Intrahepatic/*pathology ; Cholangiocarcinoma/*diagnosis/pathology/secretion ; Diagnosis, Differential ; Humans ; Male ; Mucins/*secretion

The significant advancement in cardiac imaging in recent years led to improved diagnostic accuracy in identifying the specific causes of heart failure and also provided physicians with guidelines for appropriately managing patients with heart failure. Diseases that were once considered rare are now more easily detected with the aid of cardiac imaging. Various cardiac imaging techniques are used to evaluate patients with heart failure, and each technique plays a distinct yet complementary role. This review aimed to discuss the comprehensive role of different types of cardiac imaging in the management of heart failure.

Among the therapeutic strategies in cancer immunotherapy—such as immune-modulating antibodies, cancer vaccines, or adoptive T cell transfer—T cells have been an attractive target due to their cytotoxicity toward tumor cells and the tumor antigen-specific binding of their receptors. Leveraging the unique properties of T cells, chimeric antigen receptor-T cells and T cell receptor (TCR)-T cells were developed through genetic modification of their receptors, enhancing the specificity and effectiveness of T cell therapy. Adoptive cell transfer of chimeric antigen receptor-T cells has been successful for the treatment of hematological malignancies. To expand T cell therapy to solid tumors, T cells are modified to express defined TCR targeting tumor associated antigen, which is called TCR-T therapy. This review discusses anti-tumor T cell therapies, with a focus on engineered TCR-T cell therapy.We outline the characteristics of TCR-T cell therapy and its clinical application to non-hematological malignancies.